
FDA Panel to Review Amgen’s Xgeva – Analyst Blog (Zacks)
The FDA’s Oncologic Drugs Advisory Committee (ODAC) will review Xgeva on Feb.
8, 2012.
Making Strides Against Breast Cancer North Iowa Events 2010

The FDA’s Oncologic Drugs Advisory Committee (ODAC) will review Xgeva on Feb.
8, 2012.
Making Strides Against Breast Cancer North Iowa Events 2010